Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-2-3
pubmed:abstractText
Eradication therapy with proton pump inhibitor, clarithromycin and amoxicillin fails in a considerable number of cases. A rescue therapy still fails in more than 20% of the cases. Our aim was to evaluate the efficacy and tolerability of a third-line levofloxacin-based regimen in patients with two consecutive Helicobacter pylori eradication failures.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0002-9270
pubmed:author
pubmed:issnType
Print
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
243-7
pubmed:dateRevised
2009-6-26
pubmed:meshHeading
pubmed-meshheading:16454825-Amoxicillin, pubmed-meshheading:16454825-Antacids, pubmed-meshheading:16454825-Anti-Bacterial Agents, pubmed-meshheading:16454825-Bismuth, pubmed-meshheading:16454825-Breath Tests, pubmed-meshheading:16454825-Clarithromycin, pubmed-meshheading:16454825-Drug Therapy, Combination, pubmed-meshheading:16454825-Enzyme Inhibitors, pubmed-meshheading:16454825-Female, pubmed-meshheading:16454825-Follow-Up Studies, pubmed-meshheading:16454825-Helicobacter Infections, pubmed-meshheading:16454825-Helicobacter pylori, pubmed-meshheading:16454825-Humans, pubmed-meshheading:16454825-Male, pubmed-meshheading:16454825-Metronidazole, pubmed-meshheading:16454825-Middle Aged, pubmed-meshheading:16454825-Ofloxacin, pubmed-meshheading:16454825-Omeprazole, pubmed-meshheading:16454825-Prospective Studies, pubmed-meshheading:16454825-Protein Synthesis Inhibitors, pubmed-meshheading:16454825-Tetracycline, pubmed-meshheading:16454825-Treatment Failure
pubmed:year
2006
pubmed:articleTitle
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
pubmed:affiliation
Hospital de la Princesa, Madrid, Spain.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Multicenter Study